{
    "2021-02-10": [
        [
            {
                "time": "",
                "original_text": "贝达药业，来自杭州的生物科技企业，拟香港IPO上市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "生物科技",
                        "香港IPO",
                        "上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业递交赴港IPO申请 已有两款自研癌症靶向创新药在中国上市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "赴港IPO",
                        "癌症靶向药",
                        "创新药",
                        "中国上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}